Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

Summary

This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.

Conditions

• Tobacco Product Beliefs and Use

Interventions

BEHAVIORAL

Modified Risk Claim Type - None

Participants will view smokeless tobacco ads with no modified risk claim (control)

BEHAVIORAL

Product Brand - General Snus

Participants will views ads for the smokeless tobacco brand General Snus

BEHAVIORAL

Product Brand - Copenhagen

Participants will views ads for the smokeless tobacco brand Copenhagen

BEHAVIORAL

Modified Risk Claim Type - Multiple Diseases

Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases

BEHAVIORAL

Modified Risk Claim Type - Lung Cancer

Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• Rutgers, The State University of New Jersey

  lead OTHER

Principal Investigators

• Olivia A Wackowski, PhD, MPH · Rutgers University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

21 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2025-04-24

Primary Completion

2025-05-04

Completion

2025-05-04

Countries

• United States

Study Locations